FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral Contraceptive Company's Second Proprietary Extended-Cycle OC To Be Available In July

... BarrPharmaceuticals, Inc. (NYSE: BRL) today announced that the U.S. Food andDrug Administration (FDA) has approved its Duramed Pharmaceuticals, Inc.'sNew Drug Application (NDA) for SEASONIQUE(TM) (levonorgestrel/ethinylestradiol tablets 0.15 mg/0.03 mg and ethinyl estradiol tablets 0.01 mg)extended-cycle oral contraceptive for the prevention of pregnancy. [click link for full article] ...